4//SEC Filing
Young Donald R 4
Accession 0000950170-24-066183
CIK 0001145986other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 8:27 PM ET
Size
23.9 KB
Accession
0000950170-24-066183
Insider Transaction Report
Form 4
Young Donald R
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-05-29$29.38/sh−176,746$5,192,797→ 622,880 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-05-28−108,105→ 0 totalExercise: $7.54Exp: 2025-03-11→ Common Stock (108,105 underlying) - Exercise/Conversion
Stock Options (Right to Buy)
2024-05-29−296,771→ 0 totalExercise: $6.40Exp: 2025-12-11→ Common Stock (296,771 underlying) - Exercise/Conversion
Common Stock
2024-05-28$6.40/sh+26,577$170,093→ 759,799 total - Exercise/Conversion
Common Stock
2024-05-29$6.40/sh+296,771$1,899,334→ 799,626 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-05-28−26,577→ 296,771 totalExercise: $6.40Exp: 2025-12-11→ Common Stock (26,577 underlying) - Exercise/Conversion
Common Stock
2024-05-28$10.78/sh+259,671$2,799,253→ 625,117 total - Exercise/Conversion
Common Stock
2024-05-28$7.54/sh+108,105$815,112→ 733,222 total - Sale
Common Stock
2024-05-28$29.18/sh−230,658$6,730,600→ 529,141 total - Sale
Common Stock
2024-05-28$29.72/sh−26,286$781,220→ 502,855 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-05-28−259,671→ 0 totalExercise: $10.78Exp: 2024-09-10→ Common Stock (259,671 underlying)
Footnotes (8)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10B5-1 trading plan previously adopted by the reporting person on February 26, 2024.
- [F2]The shares of common stock were sold solely to satisfy the reporting person's tax withholding obligations related to the exercise of stock options to purchase 691,124 shares as reported herein.
- [F3]These transactions were executed in multiple trades at prices ranging from $28.59 to $29.58. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F4]These transactions were executed in multiple trades at prices ranging from $29.59 to $30.00. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F5]These transactions were executed in multiple trades at prices ranging from $28.67 to $29.59. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- [F6]Represents 418,398 shares of Common Stock and 47,532 Restricted Stock Units and 156,950 shares of Restricted Stock.
- [F7]This option is fully vested and exercisable.
- [F8]The reporting person previously disclosed the grant of an aggregate of 454,926 options on December 11, 2015, including 370,181 options subject to performance conditions. Of the performance-based options, 131,578 options were previously forfeited by the reporting person as a result of the applicable performance targets not being achieved. Accordingly, an aggregate of 323,348 options remained exercisable from the December 11, 2015 grant as of the date of this Form 4.
Documents
Issuer
ASPEN AEROGELS INC
CIK 0001145986
Entity typeother
Related Parties
1- filerCIK 0001610257
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 8:27 PM ET
- Size
- 23.9 KB